BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28834954)

  • 21. Varicella in Tshuapa Province, Democratic Republic of Congo, 2009-2014.
    Leung J; McCollum AM; Radford K; Hughes C; Lopez AS; Guagliardo SAJ; Nguete B; Likafi T; Kabamba J; Malekani J; Shongo Lushima R; Pukuta E; Karhemere S; Muyembe Tamfum JJ; Reynolds MG; Wemakoy Okitolonda E; Schmid DS; Marin M
    Trop Med Int Health; 2019 Jul; 24(7):839-848. PubMed ID: 31062445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots.
    Higgins SG; Hoff NA; Gadoth A; Fusellier A; Mukadi P; Alfonso V; Randall C; Ashbaugh H; Poncheri M; Doshi RH; Gerber S; Budd R; Wolfert R; Williams R; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31413172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea.
    Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
    Int J Infect Dis; 2008 May; 12(3):245-7. PubMed ID: 17950022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.
    Davidovici BB; Balicer RD; Klement E; Green MS; Mendelson E; Smetana Z; Cohen DI
    Eur J Epidemiol; 2007; 22(9):641-6. PubMed ID: 17668279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
    Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
    Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.
    Cheng A; Ghanem-Uzqueda A; Hoff NA; Ashbaugh H; Doshi RH; Mukadi P; Budd R; Higgins SG; Randall C; Gerber S; Kabamba M; Ngoie Mwamba G; Okitolonda-Wemakoy E; Muyembe-Tanfum JJ; Rimoin AW
    PLoS One; 2022; 17(5):e0268703. PubMed ID: 35587922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.
    Kose S; Mandiracioglu A; Senger SS; Ulu Y; Cavdar G; Gol B; Gurbuz I; Sariavci S; Nohutcu N
    J Infect Public Health; 2013 Apr; 6(2):115-9. PubMed ID: 23537824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study.
    Aarnisalo J; Ilonen J; Vainionpää R; Volanen I; Kaitosaari T; Simell O
    Scand J Infect Dis; 2003; 35(10):750-3. PubMed ID: 14606615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varicella zoster virus transmission dynamics in Vojvodina, Serbia.
    Medić S; Katsilieris M; Lozanov-Crvenković Z; Siettos CI; Petrović V; Milošević V; Brkić S; Andrews N; Ubavić M; Anastassopoulou C
    PLoS One; 2018; 13(3):e0193838. PubMed ID: 29505590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.
    Dayan GH; Panero MS; Debbag R; Urquiza A; Molina M; Prieto S; Del Carmen Perego M; Scagliotti G; Galimberti D; Carroli G; Wolff C; Schmid DS; Loparev V; Guris D; Seward J
    J Clin Microbiol; 2004 Dec; 42(12):5698-704. PubMed ID: 15583301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia.
    Medić S; Petrović V; Milosević V; Lozanov-Crvenković Z; Brkić S; Andrews N; de Ory F; Anastassopoulou C
    Epidemiol Infect; 2018 Sep; 146(12):1593-1601. PubMed ID: 29909816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico.
    Alvarez y Muñoz MT; Torres J; Damasio-Santana L; Gómez A; Fernández-Quintanilla G; Tapia-Conyer R; Muñoz O
    Arch Med Res; 1999; 30(1):60-3. PubMed ID: 10071427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
    Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
    Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active circulation of varicella zoster virus among different age groups in Sudan.
    Adam O; Musa A; Kamer A; Benharrat S; Hübschen JM
    Epidemiol Infect; 2022 Dec; 151():e10. PubMed ID: 36660812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
    Kudesia G; Partridge S; Farrington CP; Soltanpoor N
    J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.